Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Avobenzone is a synthetic dibenzoylmethane derivative that serves as a broad-spectrum Ultraviolet A (UVA) filter in sunscreen formulations. It is one of the few chemical filters capable of absorbing the full range of UVA radiation (320–400 nm), including the longer UVA I wavelengths. Because avobenzone is photolabile and degrades upon exposure to sunlight, it is typically stabilized in commercial products using ingredients like octocrylene, oxybenzone, or diethylhexyl syringylidenemalonate. It is widely utilized in topical preparations to prevent sunburn, reduce the risk of skin cancer, and mitigate photoaging.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on avobenzone.